Shenan Tongluo decoction in treatment of diabetic kidney disease: Study protocol for a randomized Controlled trial
- Conditions
- Diabetic Nephropathy
- Registration Number
- ITMCTR2100005191
- Lead Sponsor
- Changchun University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
(1) At the same time, it meets the diagnostic criteria and syndrome differentiation criteria of Chinese medicine, and the diagnostic criteria of Western medicine for diabetic nephropathy.
(2) The gender is not limited, and the age range of the included patients is 18 to 65 years old.
(3) HbA1c=7%, for patients with severe complications such as recurrent hypoglycemia, severe microvascular or macrovascular complications, or patients who cannot meet the standard requirements after adequate treatment, HbA1c=8%.
(4) Control blood pressure below 130/80mmHg.
(5) The patient knows and voluntarily participates in the trial study and signs the consent form, and has good compliance.
(1) In line with the diagnostic criteria of diabetic nephropathy of Western medicine and the diagnostic criteria of Traditional Chinese medicine and syndrome differentiation criteria.
(2) Gender was not limited, and the included patients ranged from 18 to 65 years old;
(3) HbA1c=7% : for patients with serious complications such as recurrent hypoglycemia, severe microvascular or macrovascular complications, or those who still fail to meet the standard after adequate treatment, HbA1c=8%
(4) Blood pressure should be controlled below 130/80mmHg;
(5) Patients are informed and voluntarily participate in the study and sign the consent form, with good compliance.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method